Omics Research-Based Identification of Targets in Sepsis 2 (ORBITS2)

Principal Investigator: Robert Goggs

Co-PI: Marjory Brooks

Department of Clinical Sciences
Sponsor: Ethos Discovery
Title: Omics Research-Based Identification of Targets in Sepsis 2 (ORBITS2)
Project Amount: $12,442
Project Period: November 2022 to October 2023

DESCRIPTION (provided by applicant): 

This hypothesis generating study aims to identify potential theranostic and prognostic targets of septic peritonitis through platelet transcriptomic analysis using a commercial expression panel of 800 transcripts. These data will undergo bioinformatic analysis to correlate them to clinical sequelae of septic peritonitis to identify the highest value targets to investigate further in future prospective clinical trials.